Please login to the form below
Scotland
This page shows the latest Scotland news and features for those working in and with pharma, biotech and healthcare.
SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease
Under this framework, eligible children in Scotland will be able to access Crysvita while Kyowa Kirin collects additional data, to address any areas of uncertainty. ... After three years, the SMC will review the new evidence and make a final decision on
Latest news
-
Brexit nears as Conservatives sweep to victory in election
Meanwhile the pro-Remain Liberal Democrats were also punished, losing several seats including that of leader Jo Swinson in Scotland.
-
NICE backs first cannabis-based drugs, both from GW Pharma
Wales and Northern Ireland typically also follow NICE guidance, while the agency’s counterpart in Scotland – the Scottish Medicine Consortium (SMC) – is due to make a decision on Epidyolex next year.
-
UK rations AZ’s paediatric flu vaccine after delivery delays
Both Scotland and Wales have also announced plans to prioritise children with eligible health conditions, as well as the two to-five-year-old programme, in response to the delay. ... Scotland’s deputy chief medical officer Dr Gregor Smith said: “The
-
SMC approves Yescarta and Keytruda, rejects Perjeta
Last year, Gilead agreed a market access deal with NHS England for its groundbreaking CAR-T therapy Yescarta (axicabtagene ciloleucel), with the approval in Scotland extending the drug’s reach. ... Lung cancer is the most common cause of death from
-
NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig
whilst it is NHS funded in Scotland,” said Haseeb Ahmad (pictured below), managing director UK, Ireland and Nordics and Novartis president UK. ... Haseeb Ahmad. The preventative medicine is available for use in on the NHS in Scotland – this rejection
More from news
Approximately 7 fully matching, plus 228 partially matching documents found.
Latest Intelligence
-
Creativity in storytelling: why pharma must invest more in creativity
Guy Vickerstaff, Chair of IPA Scotland, said: “For all the data, for all the latest tech, for all the influencers and all the noise, it’s all too easy to lose
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
Different from the 2014 PPRS is the requirement for companies to offer the same deal – whether agreed in England, Scotland, Wales or Northern Ireland – across all nations.
-
The Orkambi row explained
May 2016: Orkambi and Kalydeco rejected in Scotland. June 2016: NICE gives final rejection of Orkambi in England – the Cystic Fibrosis Trust suggests a solution using the UK CF Registry to
-
The Orkambi blame game
Leiden added: “It could be the same price as Scotland. That’s the quickest way.”. ... Deciphering the feasibility of this hope was difficult for the MPs, as Scotland’s deal with Vertex remains confidential.
-
#OrkambiNow?
A market access deal with Scotland’s government has provided new impetus to the talks in England, with the hope that both sides can climb down and reach agreement soon.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
ClinTec International adds to senior leadership team
Prior to working for inVentiv Health, Dr Reekie served as chief operating officer at PharmaNet prior to its acquisition by inVentiv, commercial director at Stratified Medicine Scotland-Innovation Centre and head
-
ABPI Scotland appoints Sandra Auld as director
She will spearhead the ABPI Scotland team, working closely with the Scottish Government and NHS Scotland. . ... Auld added: “I am absolutely delighted to become the Director of ABPI Scotland.
-
Former RBS head takes the reins as GSK chair
Sir Philip, formerly the chair of the Royal Bank of Scotland, replaces Sir Christopher Gent, who announced he would step down from the position last year.
-
EFPIA looks to ABPI for comms director
Powrie-Smith is currently director of the ABPI's operations in Scotland and also heads the trade body's Trust and Reputation network.
-
Sir Philip Hampton set to be new GSK chair
RBS chairman to replace Sir Christopher Gent. GlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to
More from appointments
Approximately 2 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Pricing and Market Access Simulator
Germany, Italy, Netherlands, Poland, Portugal, Scotland, Spain, Sweden, and US.
-
Spotlight interview: 15 minutes on PR in pharma
Going back to my point about public relations being so diverse these days, our work is so varied whether we are supporting a reimbursement decision in Scotland to launching a global
-
What are you doing, Dave?
NHS 24 in Scotland now has a symptom checker app. Babylon, the healthcare company that offers 'virtual GP' services, has created an NHS 111 app including a paediatric symptom checker for
-
Givers and Takers
limits. And let’s not even talk about the proud descendant of an immigrant family from Scotland who wants to stop other well-intentioned immigrants from entering the USA – let’s
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
This is currently being trialled throughout England and is already widely available in Scotland.
More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.
Featured jobs
-
Senior External Communications Lead
-
£Competitive Salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Director
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
-
Publications director
-
Competitive salary and bonus scheme
- Account Director, Healthcare Communications
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- AbbVie/Allergan merger faces renewed public opposition despite divestments
- Genital herpes vaccine candidate heads for human studies
- Categories - Communiqué Awards
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
